Literature DB >> 19418565

Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.

Martin Gawlitzek1, Michael Estacio, Tobias Fürch, Robert Kiss.   

Abstract

The effect of different cell culture conditions on N-glycosylation site-occupancy has been elucidated for two different recombinant glycoproteins expressed in Chinese hamster ovary (CHO) cells, recombinant human tissue plasminogen activator (t-PA) and a recombinant enzyme (glycoprotein 2-GP2). Both molecules contain a N-glycosylation site that is variably occupied. Different environmental factors that affect the site-occupancy (the degree of occupied sites) of these molecules were identified. Supplementing the culture medium with additional manganese or iron increased the fraction of fully occupied t-PA (type I t-PA) by approximately 2.5-4%. Decreasing the cultivation temperature from 37 to 33 degrees C or 31 degrees C gradually increased site-occupancy of t-PA up to 4%. The addition of a specific productivity enhancer, butyrate, further increased site-occupancy by an additional 1% under each cultivation temperature tested. In addition, the thyroid hormones triiodothyronine and thyroxine increased site-occupancy of t-PA compared to control conditions by about 2%. In contrast, the addition of relevant nucleoside precursor molecules involved in N-glycan biosynthesis (e.g., uridine, guanosine, mannose) either had no effect or slightly reduced site-occupancy. For the recombinant enzyme (GP2), it was discovered that culture pH and the timing of butyrate addition can be used to control N-glycan site-occupancy within a specific range. An increase in culture pH correlated with a decrease in site-occupancy. Similarly, delaying the timing for butyrate addition also decreased site-occupancy of this molecule. These results highlight the importance of understanding how cell culture conditions and media components can affect the product quality of recombinant glycoproteins expressed in mammalian cell cultures. Furthermore, the identification of relevant factors will enable one to control product quality attributes, specifically N-glycan site-occupancy, within a specific range when applied appropriately. Copyright 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418565     DOI: 10.1002/bit.22348

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  17 in total

1.  Cell culture medium improvement by rigorous shuffling of components using media blending.

Authors:  Martin Jordan; Damien Voisard; Antoine Berthoud; Laetitia Tercier; Beate Kleuser; Gianni Baer; Hervé Broly
Journal:  Cytotechnology       Date:  2012-06-14       Impact factor: 2.058

Review 2.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Mechanism of bacterial oligosaccharyltransferase: in vitro quantification of sequon binding and catalysis.

Authors:  Sabina Gerber; Christian Lizak; Gaëlle Michaud; Monika Bucher; Tamis Darbre; Markus Aebi; Jean-Louis Reymond; Kaspar P Locher
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

4.  A high-throughput media design approach for high performance mammalian fed-batch cultures.

Authors:  Yolande Rouiller; Arnaud Périlleux; Natacha Collet; Martin Jordan; Matthieu Stettler; Hervé Broly
Journal:  MAbs       Date:  2013-04-05       Impact factor: 5.857

5.  Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers.

Authors:  William C Yang; Jiuyi Lu; Ngan B Nguyen; An Zhang; Nicholas V Healy; Rashmi Kshirsagar; Thomas Ryll; Yao-Ming Huang
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

6.  Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media.

Authors:  Jianlin Xu; Matthew S Rehmann; Xuankuo Xu; Chao Huang; Jun Tian; Nan-Xin Qian; Zheng Jian Li
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

7.  Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM.

Authors:  Edward S X Moh; Chi-Hung Lin; Morten Thaysen-Andersen; Nicolle H Packer
Journal:  J Am Soc Mass Spectrom       Date:  2016-04-01       Impact factor: 3.109

8.  Reduction of charge variants by CHO cell culture process optimization.

Authors:  Zhibing Weng; Jian Jin; ChunHua Shao; Huazhong Li
Journal:  Cytotechnology       Date:  2020-03-31       Impact factor: 2.058

9.  Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation.

Authors:  Bingchuan Wei; Xuan Gao; Lance Cadang; Saeed Izadi; Peilu Liu; Hui-Min Zhang; Elizabeth Hecht; Jeongsup Shim; Gordon Magill; Juan Rincon Pabon; Lu Dai; Wilson Phung; Elaine Lin; Christopher Wang; Kevin Whang; Sean Sanchez; Jose Oropeza; Julien Camperi; Jennifer Zhang; Wendy Sandoval; Yonghua Taylor Zhang; Guoying Jiang
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

10.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.